SYNLAB AG SYAB.DE Stock
SYNLAB AG Price Chart
SYNLAB AG SYAB.DE Financial and Trading Overview
SYNLAB AG stock price | 10.56 EUR |
Previous Close | 9.16 EUR |
Open | 9.17 EUR |
Bid | 9.12 EUR x N/A |
Ask | 9.14 EUR x N/A |
Day's Range | 9.11 - 9.2 EUR |
52 Week Range | 6.68 - 19.6 EUR |
Volume | 21.86K EUR |
Avg. Volume | 109.09K EUR |
Market Cap | 2.01B EUR |
Beta (5Y Monthly) | 1.022888 |
PE Ratio (TTM) | 6.019737 |
EPS (TTM) | 0.42 EUR |
Forward Dividend & Yield | 0.33 (3.60%) |
Ex-Dividend Date | May 18, 2023 |
1y Target Est | 11.2 EUR |
SYAB.DE Valuation Measures
Enterprise Value | 3.52B EUR |
Trailing P/E | 6.019737 |
Forward P/E | 19.468084 |
PEG Ratio (5 yr expected) | -0.89 |
Price/Sales (ttm) | 0.69514555 |
Price/Book (mrq) | 0.83371294 |
Enterprise Value/Revenue | 1.217 |
Enterprise Value/EBITDA | 10.881 |
Trading Information
SYNLAB AG Stock Price History
Beta (5Y Monthly) | 1.022888 |
52-Week Change | -48.27% |
S&P500 52-Week Change | 20.43% |
52 Week High | 19.6 EUR |
52 Week Low | 6.68 EUR |
50-Day Moving Average | 9.44 EUR |
200-Day Moving Average | 10.99 EUR |
SYAB.DE Share Statistics
Avg. Volume (3 month) | 109.09K EUR |
Avg. Daily Volume (10-Days) | 54.36K EUR |
Shares Outstanding | 219.7M |
Float | 50.88M |
Short Ratio | N/A |
% Held by Insiders | 24.29% |
% Held by Institutions | 70.77% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.33 |
Trailing Annual Dividend Yield | 3.60% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.21370001 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -1.28% |
Operating Margin (ttm) | 6.43% |
Gross Margin | 76.12% |
EBITDA Margin | 11.17% |
Management Effectiveness
Return on Assets (ttm) | 2.11% |
Return on Equity (ttm) | -1.47% |
Income Statement
Revenue (ttm) | 2.89B EUR |
Revenue Per Share (ttm) | 13.17 EUR |
Quarterly Revenue Growth (yoy) | -33.80% |
Gross Profit (ttm) | 2.47B EUR |
EBITDA | 323.31M EUR |
Net Income Avi to Common (ttm) | -37275000 EUR |
Diluted EPS (ttm) | 1.52 |
Quarterly Earnings Growth (yoy) | -87.099% |
Balance Sheet
Total Cash (mrq) | 458.31M EUR |
Total Cash Per Share (mrq) | 2.14 EUR |
Total Debt (mrq) | 2.01B EUR |
Total Debt/Equity (mrq) | 85.38 EUR |
Current Ratio (mrq) | 1.434 |
Book Value Per Share (mrq) | 10.975 |
Cash Flow Statement
Operating Cash Flow (ttm) | 461.16M EUR |
Levered Free Cash Flow (ttm) | 314.65M EUR |
Profile of SYNLAB AG
Country | Germany |
State | N/A |
City | Munich |
Address | Moosacher Straße 88 |
ZIP | 80809 |
Phone | 49 89 307602 0 |
Website | https://www.synlab.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 24907 |
SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers coronavirus tests, and medical and veterinary diagnostics services. SYNLAB AG was founded in 1998 and is headquartered in Munich, Germany.
Q&A For SYNLAB AG Stock
What is a current SYAB.DE stock price?
SYNLAB AG SYAB.DE stock price today per share is 10.56 EUR.
How to purchase SYNLAB AG stock?
You can buy SYAB.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SYNLAB AG?
The stock symbol or ticker of SYNLAB AG is SYAB.DE.
Which industry does the SYNLAB AG company belong to?
The SYNLAB AG industry is Diagnostics & Research.
How many shares does SYNLAB AG have in circulation?
The max supply of SYNLAB AG shares is 228.93M.
What is SYNLAB AG Price to Earnings Ratio (PE Ratio)?
SYNLAB AG PE Ratio is 25.80952500 now.
What was SYNLAB AG earnings per share over the trailing 12 months (TTM)?
SYNLAB AG EPS is 0.42 EUR over the trailing 12 months.
Which sector does the SYNLAB AG company belong to?
The SYNLAB AG sector is Healthcare.